Abstract:Background This study analyzes the RSV season 2021/2022 in a referral children's hospital, compares the epidemiology and illness severity with RSV-infected inpatients from 2016 to 2020 and audits the adherence to our internal therapy standard for RSV bronchiolitis. Material and methods Inpatients with rtPCR-confirmed RSV infection (Jan. 2016 to Jan. 2022). Results The audit comprises 306 RSV inpatients, on average 50 hospitalizations per year; in 03/2020, a rapid RSV Season-Offset was observed. In the winter season 2020/2021, no patient with RSV was hospitalized. Beginning in July, we noticed a rapid increase of RSV-admissions (most cases in Sept./Oct, duration until Dec. 2021; n=53). In 2021–2022, a significant larger share needed PICU admission (9.4% vs 3.2%, p=0.040). Adherence to the internal guidance was low; only 11.8% (n=36) of all patients received supportive treatment without inhalative or systemic medications, 37% of all patients received antibiotics. Conclusions This audit confirms the strong impact of public preventive measures directed against SARS-CoV-2 transmission on RSV epidemiology. Few weeks after easing public COVID-19 restrictions (summer 2021), RSV inpatient cases rapidly increased, lasting until Dec. 2021. The audit of bronchiolitis management revealed surprisingly low adherence to the internal guidance, despite a face-to-face educational session with the attending pediatricians in Oct. 2021. Low adherence resulted in an unnecessary exposure of RSV patients to systemic medications of questionable benefit including antibiotics. Hintergrund In dieser Studie erfolgte eine prospektive Analyse der RSV Saison 2021/2022 in einem Universitätsklinikum. Dabei wurde die klinische Epidemiologie und der Schweregrad mit Daten RSV-infizierter Patienten von 2016–2020 verglichen. Zusätzlich wurde die Adhärenz zu einem internen Standard zur Therapie der RSV-Bronchiolitis überprüft. Material und Methoden Stationäre Patienten mit rtPCR-bestätigter RSV-Infektion (Jan. 2016 bis Jan. 2022) Ergebnisse Insgesamt wurden 306 stationär behandelten RSV-infizierte Patienten eingeschlossen, im Mittel 50 Kinder pro Jahr. Im März 2022 kam es zu einer raschen Abnahme der RSV Prävalenz. Ab Juli 2021 erfolgte dann ein steiler Anstieg mit (Maximum im Sept./Okt). dann eine abnehmende Zahl bis Dez. 2021 (n=53). 2021/2022 war der Anteil intensivmedizinisch behandelter Kinder signifikant höher (9,4% vs. 3,2% 2016–2020, p=0,040). Die Adhärenz zum klinikinternen Behandlungsstandard war niedrig, nur 11.8% der Patienten erhielten ausschließlich eine supportive Behandlung ohne weitere inhalative oder systemische Therapie, 37% der Patienten erhielten Antibiotika. Zusammenfassung Dieses Audit bestätigt den starken Einfluss des SARS-CoV-2- Infektionsschutzes auf die RSV Epidemiologie. Nach Beendigung der Schutzmaßnahmen gab es im Sommer 2021 einen Anstieg stationär behandelter RSV-Infektionen bis Dez. 2021. Die Adhärenz zum internen Behandlungsstandard war trotz einer erneuten Schulung des Personals (2021) niedrig, was zu einer hohen Exposition gegenüber wenig evidenz-basierten Therapien und Antibiotika führte. Article published online: 06 February 2024 © 2024. Thieme. All rights reserved. Georg Thieme Verlag Rüdigerstraße 14, 70469 Stuttgart, Germany

Characteristics and outcomes of patients hospitalized for infection with Influenza A, SARS-CoV-2 or respiratory syncytial virus in the season 2023/2024 in a large German primary care centre

Focusing on severe infections with the Respiratory Syncytial Virus (RSV) in adults: risk factors, symptomatology and clinical course compared to influenza A / B and the original SARS-CoV-2 strain

Respiratory Syncytial Virus in Adult Patients at a Tertiary Care Hospital in Germany: Clinical Features and Molecular Epidemiology of the Fusion Protein in the Severe Respiratory Season of 2022/2023

Atypical age distribution and high disease severity in children with RSV infections during two irregular epidemic seasons throughout the COVID-19 pandemic, Germany, 2021 to 2023

Influenza and RSV incidence during COVID-19 pandemic—an observational study from in-hospital point-of-care testing

Characterisation of RSV infections in children without chronic diseases aged 0–36 months during the post-COVID-19 winter season 2022/2023

Respiratory virus disease and outcomes at a large academic medical center in the United States: a retrospective observational study of the early 2023/2024 respiratory viral season

Change of Epidemiological Characteristics of Four Respiratory Viral Infections in Children Before and During COVID-19 Pandemic.

Epidemiological Trend of RSV Infection Before and During COVID-19 Pandemic: A Three-Year Consecutive Study in China

Old foes following news ways?-Pandemic-related changes in the epidemiology of viral respiratory tract infections

The severity of respiratory syncytial virus infection in children during the SARS-CoV-2/COVID-19 pandemic: A nationwide study of 11,915 cases in Germany

Clinical Manifestations and Outcomes in Adults Hospitalized With Respiratory Syncytial Virus and Influenza a/B: A Multicenter Observational Cohort Study

Respiratory Syncytial Virus and Influenza During the COVID-19 Pandemic: A Two-center Experience

The surge of RSV and other respiratory viruses among children during the second COVID-19 pandemic winter season

The impact of the COVID-19 pandemic on respiratory failure caused by respiratory viruses in children and adolescents

Cocirculation and coinfection of multiple respiratory viruses during autumn and winter seasons of 2023 in Beijing, China: A retrospective study

Features of respiratory syncytial virus infection in children in the post-COVID 19 era

Assessing respiratory viral exclusion and affinity interactions through co-infection incidence in a pediatric population during the 2022 resurgence of influenza and RSV

Inconsistent increase in age at RSV hospitalisation of children <2 years during the SARS-CoV-2 pandemic: a retrospective multicentre study in four European countries

Inpatient Rsv-Management 2016–2022: Epidemiology and Adherence to A Bronchiolitis Treatment Standard at a German University Children's Hospital

Prevalence of Co-Infections in Primary Care Patients with Medically Attended Acute Respiratory Infection in the 2022/2023 Season